Indian Rituximab Exporters: Complete Supplier Ranking with Market Share — 164 Manufacturers (2026) — TransData Nexus

Q: Who is the largest rituximab supplier from India?

DR.REDDY'S LABORATORIES LTD is the largest rituximab exporter from India with a 41.5% market share and export value of $7.9M.

Q: How many rituximab suppliers are there in India?

There are 164 active rituximab exporters in India, collectively shipping $19.1M worth of rituximab across 1,215 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top rituximab suppliers from India?

The top 5 rituximab suppliers from India — DR.REDDY'S LABORATORIES LTD, RELIANCE LIFE SCIENCES PRIVATE LIMITED, DR REDDYS LABORATORIES LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, HETERO BIOPHARMA LIMITED — together control 87.1% of total rituximab export value from India.

Suresh Sormare

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Rituximab Suppliers from India (2026) — 164 Exporters, $19.1M Market | TransData Nexus | TransData Nexus

Who Exports Rituximab from India — 164 Suppliers Behind a $19.1M Market

India's rituximab export market is supplied by 164 active exporters who collectively shipped $19.1M across 1,215 shipments. DR.REDDY'S LABORATORIES LTD leads with a 41.5% market share, followed by RELIANCE LIFE SCIENCES PRIVATE LIMITED and DR REDDYS LABORATORIES LIMITED. The top 5 suppliers together control 87.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Rituximab Suppliers & Exporters — 164 manufacturers, $19.1M export market, top destinations and formulations — Rituximab supplier data — 164 exporters · $19.1M market · 1,215 shipmentsTransData Nexus · Indian Customs Data

Top Rituximab Exporters from India — Ranked by Export Value

DR.REDDY'S LABORATORIES LTD is the leading rituximab exporter from India, holding a 41.5% share of the $19.1M market across 1,215 shipments from 164 exporters. The top 5 suppliers — DR.REDDY'S LABORATORIES LTD, RELIANCE LIFE SCIENCES PRIVATE LIMITED, DR REDDYS LABORATORIES LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, HETERO BIOPHARMA LIMITED — collectively control 87.1% of total export value, indicating a highly concentrated market. Individual shares are: DR.REDDY'S LABORATORIES LTD (41.5%), RELIANCE LIFE SCIENCES PRIVATE LIMITED (21.4%), DR REDDYS LABORATORIES LIMITED (13.8%), MEDWISE OVERSEAS PRIVATE LIMITED (5.7%), HETERO BIOPHARMA LIMITED (4.7%).

Top Rituximab Exporters from India

Ranked by export value · 164 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Rituximab Exporters from India — Ranked by Export Value. 164 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Rituximab exporters

Certification and compliance status for top Rituximab suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
DR. REDDY'S LABORATORIES LTD	Approved	Yes	Yes	Multiple	Facilities regularly audited by USFDA, EMA, WHO GMP, and others.
HETERO BIOPHARMA LIMITED	Approved	Yes	Yes	Multiple	Facilities inspected and approved by USFDA, WHO, and EMA.
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Manufacturing facilities comply with USFDA, WHO, and EMA standards.
RELIANCE LIFE SCIENCES PRIVATE LIMITED	Approved	Yes	Yes	Multiple	Facilities meet USFDA, WHO, and EMA regulatory requirements.
DR REDDYS LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	Regularly audited by USFDA, EMA, and WHO GMP.
MEDWISE OVERSEAS PRIVATE LIMITED	Not Listed	Yes	Yes	Not Listed	Complies with WHO and EU GMP standards.
INVEX HEALTH PRIVATE LIMITED	Not Listed	Yes	Yes	Not Listed	Holds WHO and EU GMP certifications.
J.A. UNITED EXPORTS PRIVATE LIMITED	Not Listed	Yes	Yes	Not Listed	Certified under WHO and EU GMP guidelines.
R.S. SURGIPHARM PRIVATE LIMITED	Not Listed	Yes	Yes	Not Listed	Compliant with WHO and EU GMP standards.
RMPL PHARMA LLP	Not Listed	Yes	Yes	Not Listed	Holds WHO and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 10 leading Rituximab exporters from India. 5 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Rituximab sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's bulk drug capital, is a central hub for active pharmaceutical ingredients (APIs) and biologics. The city's Genome Valley anchors R&D and biologics, while legacy industrial areas host APIs and intermediates. Hyderabad Pharma City, an integrated cluster, is progressing to consolidate APIs, formulations, and support services with common utilities and effluent treatment plants. This ecosystem supports companies like Dr. Reddy's Laboratories Ltd., which accounted for 41.5% of Rituximab exports, totaling $7.9 million.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. This region hosts numerous manufacturing facilities specializing in finished dosage forms, including injectables and biosimilars. Companies such as Intas Pharmaceuticals Limited, contributing 0.8% to Rituximab exports, benefit from the well-established infrastructure and skilled workforce in this area.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a strategic export gateway for pharmaceutical products. Mumbai, being the headquarters for major pharmaceutical companies like Cipla, facilitates global distribution networks. The proximity to major ports enhances the export efficiency of companies operating in this region.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Rituximab exporters from India

February 2023

M&A

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Mayne Pharma's U.S. generic portfolio

Dr. Reddy's Laboratories entered into a definitive agreement to acquire Mayne Pharma's U.S. generic prescription product portfolio, including approximately 45 commercial products, four pipeline products, and 40 approved non-marketed products. - IMPACT: This acquisition is expected to enhance Dr. Reddy's product offerings in the U.S. market, potentially increasing resources for Rituximab exports.

Impact: This acquisition is expected to enhance Dr. Reddy's product offerings in the U.S. market, potentially increasing resources for Rituximab exports.

February 2026

M&A

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires India trademarks for two HRT drugs

Dr. Reddy's Laboratories acquired the India trademarks for specialty brands Progynova® and Cyclo-Progynova® from Mercury Pharma Group Limited for $32.15 million, strengthening its gynecology portfolio in India. - IMPACT: This acquisition may bolster Dr. Reddy's domestic market presence, potentially influencing its global export strategies, including Rituximab.

Impact: This acquisition may bolster Dr. Reddy's domestic market presence, potentially influencing its global export strategies, including Rituximab.

Common Questions — Rituximab Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which rituximab supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, DR.REDDY'S LABORATORIES LTD leads with 64 recorded shipments worth $7.9M. RELIANCE LIFE SCIENCES PRIVATE LIMITED (102 shipments) and DR REDDYS LABORATORIES LIMITED (11 shipments) are also established high-volume exporters.

Q How many rituximab manufacturers are there in India?

India has 164 active rituximab exporters with a combined export market of $19.1M across 1,215 shipments to 104 countries. The top 5 suppliers hold 87.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for rituximab from India?

Average FOB unit price: $104.42 per unit, ranging from $0.01 to $2534.33. Average shipment value: $15.7K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rituximab

Rituximab

Who Exports Rituximab from India — 164 Suppliers Behind a $19.1M Market

Top Rituximab Exporters from India — Ranked by Export Value

Top Rituximab Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Mayne Pharma's U.S. generic portfolio

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires India trademarks for two HRT drugs

Common Questions — Rituximab Suppliers from India

Q Which rituximab supplier from India is the most reliable for bulk orders?

Q How many rituximab manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for rituximab from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's sells Louisiana subsidiary

Analysis Methodology